Colorectal carcinoma with sarcomatoid component: isolated SMARCA2 loss and high PD-L1 expression as a potential therapeutic target

dc.contributor.authorAknar, Furkan
dc.contributor.authorSoylemez-Akkurt, Tuce
dc.contributor.authorKaratay, Huseyin
dc.date.accessioned2025-11-16T19:34:12Z
dc.date.issued2025
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.1111/his.70012
dc.identifier.issn0309-0167
dc.identifier.issn1365-2559
dc.identifier.pmid40981612
dc.identifier.scopus2-s2.0-105016803772
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1111/his.70012
dc.identifier.urihttps://hdl.handle.net/20.500.14730/15278
dc.identifier.wosWOS:001576963200001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofHistopathology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleColorectal carcinoma with sarcomatoid component: isolated SMARCA2 loss and high PD-L1 expression as a potential therapeutic target
dc.typeLetter

Dosyalar